GlassScriptPhysician profile
Sushma Dangi
NPI 1093339053
$2,323.66
in general payments reported to CMS, 2019-2025
16 companies · $23.72 in 2025
The $23.72 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $459 · 2022: $1,322 · 2023: $190 · 2024: $329 · 2025: $23.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $1,200.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $223.15 | 2021 | |
| Amgen INC. | $159.30 | 2021-2023 | Repatha |
| Abbvie INC. | $139.80 | 2021-2024 | |
| Pfizer INC. | $128.43 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $99.82 | 2023-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $76.65 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.53 | 2024-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $54.23 | 2023-2024 | Dificid |
| Otsuka America Pharmaceutical, INC. | $46.14 | 2022 | |
| Heartflow, INC. | $29.29 | 2024 | |
| Supernus Pharmaceuticals, INC. | $23.24 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $21.05 | 2023 | Camzyos |
| Cumberland Pharmaceuticals, INC. | $20.30 | 2024 | Caldolor |
| Banner Life Sciences, LLC | $17.08 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $16.65 | 2023 | Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sushma Dangi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.